Medicine, Endocrinology Division

Grants

Grants per year 1999 2009 2012 2016 2026

• 58 Active
• 320 Finished

Grants per year

Search results

• Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer

  Abdulkadir, S. A., Chakravarti, D. & Barish, G. D.

  National Cancer Institute

  7/1/15 → 6/30/21

  Project: Research project

  • prostatic neoplasms 100%
  • epigenetics 60%
  • receptors 41%
  • threonine 25%
  • phosphorylation 22%

• NW University Program in Endo Diabetes and Hormone Action

  Dunaif, A. E. & Hayes, M. G.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/16 → 6/30/21

  Project: Research project

  • Endocrinology 100%
  • Mentors 75%
  • Hormones 46%
  • Big Data 32%
  • Organized Financing 28%

• Prot# OOC-ACM-303: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Octreotide Capsules in Patients Who Previously Tolerated and Demonstrated Biochemical Control on Injectable Somatostatin Recep

  Molitch, M. E.

  Pharm-Olam International Ltd., Chiasma, Inc.

  7/6/18 → 7/6/21

  Project: Research project

• Adaptation and Integration of a Telehealth Diabetes Discharge Toolkit for the COVID-19 Era

  Wallia, A.

  University of Chicago, National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/20 → 7/31/21

  Project: Research project

  • Telemedicine 100%
  • Patient Transfer 62%
  • Self-Directed Learning 40%
  • Transitional Care 37%
  • Education 33%

• The effects of capsinoids on brown adipose tissue recruitment and activation in obesity

  Neff, L. M., Wallia, A., Wang, X. & Kwasny, M. J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/21/16 → 8/31/21

  Project: Research project

  • Brown Adipose Tissue 100%
  • Obesity 38%
  • Energy Metabolism 32%
  • Weight Loss 23%
  • Eating 21%

• Nuclear Repressors in Genomic Control of Healthful Obesity

  Barish, G. D. & Bass, J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  5/10/16 → 9/16/21

  Project: Research project

  • B-Cell Lymphoma 100%
  • Adipose Tissue 64%
  • Insulin Resistance 47%
  • Obesity 47%
  • Abdominal Obesity 43%

• Integration of Feeding Time and Glucose Metabolism by the Circadian Gene Network

  Bass, J., Ramsey, K. M. & Turek, F. W.

  National Institute of Diabetes and Digestive and Kidney Diseases

  6/1/16 → 9/16/21

  Project: Research project

  • Gene Regulatory Networks 100%
  • Glucose 75%
  • Organized Financing 65%
  • Obesity 51%
  • Insulin Secretion 36%

• Prot# I8B-MC-ITRO: A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion PRONTO-Pump-2

  Aleppo, G.

  Lilly USA, LLC

  4/25/19 → 10/15/21

  Project: Research project

• Emergency funds critical to support diabetes clinics in providing essential medical care to vulnerable T1D populations impacted by the COVID-19 pandemic

  Aleppo, G.

  Leona M. and Harry B. Helmsley Charitable Trust

  4/1/20 → 11/30/21

  Project: Research project

  • Financial Management 100%
  • Pandemics 92%
  • Vulnerable Populations 90%
  • Telemedicine 72%
  • Emergencies 67%

• Prot #P012-001V: Pivotal Aspiration Therapy with Adjusted Lifestyle (PATHWAY) Study

  Kushner, R. F.

  Aspire Bariatrics, Inc.

  12/7/12 → 12/7/21

  Project: Research project

• Development and Evaluation of an Electronic health Record-based Medication Complete Communication (EMC2) Strategy

  Wolf, M., Curtis, L. M. & Wallia, A.

  Eli Lilly and Company

  12/1/15 → 12/31/21

  Project: Research project

• Prot# OOC-ACM-302: A Phase 3, Randomized, Open-Label, Active Controlled, Multicenter Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated with Octreotide Capsules, and in Patients Treated with Stan

  Huang, W. & Molitch, M. E.

  Pharm-Olam International Ltd., Chiasma, Inc.

  3/18/16 → 1/24/22

  Project: Research project

• ELLAS: Environment, Leiomyomas, Latinas and Adiposity Study

  Carnethon, M. R. & Neff, L. M.

  University of Michigan, National Institute on Minority Health and Health Disparities

  2/1/17 → 1/31/22

  Project: Research project

  • Leiomyoma 100%
  • Hispanic Americans 64%
  • Adiposity 52%
  • Growth 14%
  • Population 9%

• Chicago Center for Diabetes Translation Research

  Wallia, A. & Rees Lewis, D. G.

  University of Chicago, National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/21 → 1/31/22

  Project: Research project

  • Telemedicine 100%
  • Patient Transfer 71%
  • Self-Directed Learning 46%
  • Transitional Care 43%
  • Education 37%

• Study of Ovarian Aging and Reserve in Young Women (SOAR)

  Neff, L. M.

  University of Michigan, National Institute of Child Health and Human Development

  4/1/18 → 1/31/22

  Project: Research project

• Prot#PTL-902822: Continuous Glucose MOnitoring in T2D Basal InsuLin UsErs: The MOBILE Study

  Aleppo, G.

  DexCom, Inc.

  3/6/19 → 3/6/22

  Project: Research project

• Dissecting Carbohydrate-Mediated Regulation of Gut-Brain Communication

  Beutler, L. R.

  University of Chicago, National Institute of Diabetes and Digestive and Kidney Diseases

  4/1/20 → 3/31/22

  Project: Research project

  • Nutrients 100%
  • Carbohydrates 80%
  • Neurons 61%
  • Communication 56%
  • Psychological Inhibition 54%

• Evaluating Affective and Unified Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control

  Aleppo, G.

  University of California, San Francisco, National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/20 → 3/31/22

  Project: Research project

  • Pamphlets 100%
  • Organizations 68%
  • Postcards 66%
  • National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 66%
  • Consent Forms 55%

• Hypoglycemia: Risk Factors, Fragmentation of Care and Mortality Across Chicago A Study of the Chicago HealthLNK Data Repository

  Wallia, A. & Rosenman, M. B.

  Novo Nordisk Inc.

  11/1/17 → 4/1/22

  Project: Research project

  • Diabetic Ketoacidosis 100%
  • Hypoglycemia 60%
  • Diabetes Mellitus 24%
  • Mortality 23%
  • Type 2 Diabetes Mellitus 23%

• Prot#: ISIS 766720-CS2: A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of ISIS 766720 (IONIS GHR-LRX, an Antisense Inhibitor of the Growth Hormone Receptor) Administered Once Every 28 Days for 16 Weeks i

  Huang, W. & Molitch, M. E.

  Medpace Clinical Research LLC, Ionis Pharmaceuticals, Inc.

  4/3/19 → 4/3/22

  Project: Research project

• Prot:I8F-MC-GPGM: Efficacy and Safety of Tirzepatide Once Weekly versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

  Aleppo, G.

  Lilly USA, LLC

  4/12/19 → 4/12/22

  Project: Research project

• Mechanisms of Cadmium Induced Dysglycemia and Type 2 Diabetes Mellitus

  El Muayed, M., Allen, N. B. & O'Halloran, T. V.

  National Institute of Environmental Health Sciences

  9/15/17 → 5/31/22

  Project: Research project

  • Cadmium 100%
  • Type 2 Diabetes Mellitus 56%
  • Insulin 55%
  • Insulin Secretion 27%
  • Prediabetic State 17%

• Targeting BCL6 for Non-Alcoholic Fatty Liver Disease

  Barish, G. D.

  Boehringer Ingelheim International GmbH

  12/23/20 → 6/22/22

  Project: Research project

  • Non-alcoholic Fatty Liver Disease 100%
  • Fatty Liver 26%
  • Obesity 26%
  • Diabetes Mellitus 19%
  • Type 2 Diabetes Mellitus 18%

• Control of islet beta specific Pdx-1 and MafA transcription

  Bass, J.

  Vanderbilt University, National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/17 → 6/30/22

  Project: Research project

  • Bass 100%
  • Weaning 48%
  • Insulin Secretion 45%
  • Genome 30%
  • Circadian Clocks 28%

• Subproject for Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids

  Barish, G. D.

  National Institute of Child Health and Human Development

  9/16/16 → 6/30/22

  Project: Research project

  • Leiomyoma 100%
  • Epigenomics 57%
  • Computational Biology 52%
  • Genomics 51%
  • Epigenome 26%